Literature DB >> 3005316

Angiotensin II and dopamine modulate both cAMP and inositol phosphate productions in anterior pituitary cells. Involvement in prolactin secretion.

A Enjalbert, F Sladeczek, G Guillon, P Bertrand, C Shu, J Epelbaum, A Garcia-Sainz, S Jard, C Lombard, C Kordon.   

Abstract

Despite their opposite effects on prolactin secretion, both dopamine and angiotensin II inhibit adenylate cyclase activity in homogenates of anterior pituitary cells in primary culture. Dopamine and angiotensin II inhibition of adenylate cyclase was not additive, suggesting that both neurohormones inhibit the adenylate cyclase of the lactotroph cells. Pretreatment with Bordetella pertussis toxin (islet activator protein) completely suppressed the dopamine-induced inhibition of both adenylate cyclase and prolactin secretion. The islet activator protein also reversed the angiotensin II-induced inhibition of the adenylate cyclase activity. In contrast, angiotensin II stimulation of prolactin release was not affected by the toxin. Angiotensin II also induced a dose-dependent stimulation of inositol phosphates (250%) with an EC50 of 0.1 nM, close to that observed for prolactin secretion. Islet activator protein pretreatment did not block the stimulation of inositol phosphate production. Dopamine inhibited the angiotensin II-stimulated prolactin release and the production of inositol phosphates induced by angiotensin II. It is concluded that angiotensin II and dopamine receptors of lactotroph cells are able to modulate both cAMP and inositol phosphate production. The dopamine receptor of lactotrophs appears to be the first example of a receptor which is negatively coupled to the production of inositol phosphates.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3005316

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Differential action of two prolactin isoforms on ischemia and re-perfusion-induced arrhythmias in rats in vivo.

Authors:  T F Krzeminski; K Mitrega; M Porc; M Zorniak; F Ryszka; Z Ostrowska; B Kos-Kudła
Journal:  J Endocrinol Invest       Date:  2010-10-04       Impact factor: 4.256

Review 2.  Angiotensin and calcium signaling in the pituitary and hypothalamus.

Authors:  Cecilia Suárez; Isabel García Tornadú; Carolina Cristina; Jorge Vela; Arturo González Iglesias; Carlos Libertun; Graciela Díaz-Torga; Damasia Becu-Villalobos
Journal:  Cell Mol Neurobiol       Date:  2002-06       Impact factor: 5.046

Review 3.  Inositol-lipid-specific phospholipase C isoenzymes and their differential regulation by receptors.

Authors:  S Cockcroft; G M Thomas
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

4.  B-HT 920 activates dopamine D2 receptors coupled to inhibition of adenylate cyclase activity.

Authors:  P Onali; M C Olianas
Journal:  J Neural Transm Gen Sect       Date:  1992

Review 5.  Receptors and transduction mechanisms in anterior pituitary: primary cultures, transfected clonal cells and human tumor derived cells.

Authors:  A Enjalbert
Journal:  Cell Biol Toxicol       Date:  1992 Jul-Sep       Impact factor: 6.691

6.  Measles virus modulates human T-cell somatostatin receptors and their coupling to adenylyl cyclase.

Authors:  S Krantic; A Enjalbert; C Rabourdin-Combe
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

7.  Neuropharmacology of dopamine receptors:: Implications in neuropsychiatric diseases.

Authors:  F I Tarazi
Journal:  J Sci Res Med Sci       Date:  2001-10

Review 8.  Pharmacological and molecular basis for dopamine D-2 receptor diversity.

Authors:  M Memo
Journal:  Mol Neurobiol       Date:  1990 Fall-Winter       Impact factor: 5.590

9.  Proceedings of the British Pharmacological Society. 6th-8th January, 1988. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1988-03       Impact factor: 8.739

10.  Assembly and sealing of tight junctions: possible participation of G-proteins, phospholipase C, protein kinase C and calmodulin.

Authors:  M S Balda; L González-Mariscal; R G Contreras; M Macias-Silva; M E Torres-Marquez; J A García-Sáinz; M Cereijido
Journal:  J Membr Biol       Date:  1991-06       Impact factor: 1.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.